Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Witte

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2022
Development of a consensus-based delineation guideline for locally recurrent rectal cancerFloor Piqeur, Britt J P Hupkens, Stefi Nordkamp, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
JCO Clinical Cancer Informatics|January 24, 2019
Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and ResectionsDomenique M J Müller, Pierre A J T Robe, Roelant S Eijgelaar, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
European Radiology|November 7, 2019
Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methodsA de Sitter, M Visser, I Brouwer, et al.
British Journal of Pharmacology|May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory propertiesM I Strakhova, C A Cuff, A M Manelli, et al.
Radiology. Artificial Intelligence|May 3, 2021
Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified TrainingRoelant S Eijgelaar, Martin Visser, Domenique M J Müller, et al.
Journal of Medicinal Chemistry|September 25, 2008
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligandsRobert J Altenbach, Ronald M Adair, Brian M Bettencourt, et al.
Biochemical Pharmacology|March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activityMarlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2022
Development of a consensus-based delineation guideline for locally recurrent rectal cancerFloor Piqeur, Britt J P Hupkens, Stefi Nordkamp, et al.
Pharmacology, Biochemistry, and Behavior|December 17, 2009
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in ratsGin C Hsieh, Prasant Chandran, Anita K Salyers, et al.
JCO Clinical Cancer Informatics|January 24, 2019
Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and ResectionsDomenique M J Müller, Pierre A J T Robe, Roelant S Eijgelaar, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
European Radiology|November 7, 2019
Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methodsA de Sitter, M Visser, I Brouwer, et al.
British Journal of Pharmacology|May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory propertiesM I Strakhova, C A Cuff, A M Manelli, et al.
Radiology. Artificial Intelligence|May 3, 2021
Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified TrainingRoelant S Eijgelaar, Martin Visser, Domenique M J Müller, et al.
Journal of Medicinal Chemistry|September 25, 2008
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligandsRobert J Altenbach, Ronald M Adair, Brian M Bettencourt, et al.
Biochemical Pharmacology|March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activityMarlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Pageof 16